Pharmacological elimination of motion artifacts during optical imaging of cardiac tissues: is blebbistatin the answer?
Li
Danshi
D
Nattel
Stanley
S
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D016477:Artifacts; D004562:Electrocardiography; D022062:Electrophysiologic Techniques, Cardiac; D006325:Heart Atria / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006576:Heterocyclic Compounds, 4 or More Rings / Q000494:pharmacology*; D006801:Humans; D009038:Motion; D009200:Myocardial Contraction / Q000187:drug effects*; D012849:Sinoatrial Node / Q000187:drug effects / Q000502:physiology; D014475:Uncoupling Agents / Q000494:pharmacology*; D016276:Ventricular Function
D006576:Heterocyclic Compounds, 4 or More Rings; D014475:Uncoupling Agents; C472645:blebbistatin